Dr. Muriel Brackstone is Chair/Chief, Division of General Surgery, Department of Surgery at  London Health Sciences Centre.

Dr. Brackstone attended Western University, where she received an Honours Bachelor of Science in Physiology in 1992, and a Master’s degree in Neurosciences in 1994. She attended Medical School at Western University and graduated in 1999 (Gold Medalist). She received her training in General Surgery in London, Ontario and became a Fellow of the Royal College of Surgeons in 2004, concurrently with her PhD in Clinical Epidemiology & Biostatistics. Her fellowship in Breast Surgical Oncology was completed at the University of Toronto in 2005 under Dr. Claire Holloway and Dr. David McCready at Sunnybrook and Princess Margaret Hospitals. She joined the Divisions of General Surgery and Surgical Oncology in London, Ontario in August 2005. She completed a Master’s Degree in Clinical Epidemiology and Biostatistics from Western University in 2008 followed by a PhD in Pathology (Clinical Trials) from Western University from 2009-2014.
Her research interests include breast ultrasound to improve lumpectomy techniques, translational breast cancer research, and specialty clinics for Locally Advanced Breast Cancer (LABC) patients and Young Women with Breast Cancer (fertility and genetics issues). Other clinical interests include thyroid surgery, laparoscopic procedures and a varied general surgical practice. Dr. Brackstone created and became founding Medical Director for London’s multidisciplinary Breast Care Clinic from 2010 to present. In 2013, she also created the London Tumour Biobank as a biospecimen and patient data repository for translational research in collaboration with scientists across the region. She has designed and conducted a number of clinical trials and has developed the Breast Clinical Research Unit for this purpose. She sits on the breast cancer executive for the National Cancer Institute of Canada and Cancer Care Ontario and holds many national level grants. Her research interests include health outcomes, translational breast cancer research, neoadjuvant window of opportunity trials and locally advanced breast cancer.